Trans-Mitral Valve Repair Gains Medicare Coverage-With-Evidence Proposal
This article was originally published in The Gray Sheet
Executive Summary
A new draft national Medicare coverage policy offers to pay for transcatheter mitral valve repair procedures with devices like Abbott’s MitraClip only if they are conducted by a qualified heart team and are part of a national registry.
You may also be interested in...
MitraClip Medicare Gains: National Coverage Follows Bonus Payment Decision
CMS finalized a national coverage determination for transcatheter mitral valve repair, conditioned on a registry and on minimum facility and experience requirements for hospitals. The policy follows close behind a new-technology add-on payment granted to Abbott’s MitraClip device.
TAVR Gets Love, MitraClip Gets None In Medicare Inpatient Proposal
CMS proposes to grant new hospital inpatient payment categories for transcatheter valve replacements, a potential boon to Edwards’ and Medtronic’s devices. But the Medicare agency continues to stand firm against upgrading payment levels for Abbott’s MitraClip percutaneous mitral valve repair procedure.
News Briefs: Approvals For Abbott’s MitraClip, Allergan’s Juvéderm; Diagnostics News
FDA approved Abbott’s MitraClip to treat mitral regurgitation and Allergan’s Juvéderm Voluma XC facial filler to temporary correct volume-loss. Hepatitis C testing will be mandatory in New York. More news.